跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
首页
药物
ESCAPE-1
ESCAPE-1
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
Preparation method of in-vivo escape carrier cyclic peptide (CP-1)
申请人: NANJING SHENGTAI MEDICAL TECH CO LTD
优先权: 2023
CN
HIV-1 GP120 CD4 binding site antibodies targeting HIV escape mutants
申请人: CALIFORNIA INST OF TECHN
优先权: 2017
US
2 件公开
CAR-T (chimeric antigen receptor-T) carrier targeted at EGFRvIII to interfere PD-1 and reduce tumor immune escape and construction method and application
申请人: SHANGHAI SHENGBO BIOMEDICAL TECH CO LTD
优先权: 2016
CN
siRNA knocking down human PD-1 and recombinant expression CAR-T vector and their construction methods and applications
申请人: SHANGHAI UNICAR THERAPY BIO MEDICINE TECH CO LTD
优先权: 2016
US
Preparing method of 1-MT-carboxymethyl chitosan drug
申请人: UNIV WUHAN TECH
优先权: 2019
CN
Application of caffeic acid in treatment of lung cancer
申请人: NANJING ZHICHU BIOTECHNOLOGY CO LTD
优先权: 2025
CN
CAR-T vector capable of targeting Her2 and disturbing PD-L1 to reduce tumor immune escape and construction method and use thereof
申请人: SHANGHAI SHENGBO BIOMEDICAL TECH CO LTD
优先权: 2016
CN
Eimeria tenella apical membrane antigen 1 (AMA 1) gene and application thereof
申请人: SHANGHAI VETERINARY RES INST CAAS
优先权: 2011
CN
药物
反馈